LLY Aug 2024 750.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:22PM EDT. Market open.
| Previous close | 8.31 |
| Open | 8.40 |
| Bid | 7.10 |
| Ask | 7.50 |
| Strike | 750.00 |
| Expiry date | 2024-08-16 |
| Day's range | 7.25 - 8.40 |
| Contract range | N/A |
| Volume | |
| Open interest | 193 |
Yahoo FinanceEli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes with ongoing criticism about pricing and access.
Investor's Business DailyEli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
Eli Lilly stock inched ahead Monday as a panel of advisors to the FDA gathered to discuss its experimental Alzheimer's treatment, donanemab.
ZacksBiogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
FDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of Alzheimer's drug Leqembi. The final FDA decision is expected on Jan 25, 2025.
© 2024 Yahoo. All rights reserved.